Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia
Erika Bereczki, Paul T. Francis, David Howlett, et al.
Alzheimer s & Dementia (2016) Vol. 12, Iss. 11, pp. 1149-1158
Open Access | Times Cited: 147

Showing 1-25 of 147 citing articles:

Cognitive decline in Parkinson disease
Dag Aarsland, Byron Creese, Marios Politis, et al.
Nature Reviews Neurology (2017) Vol. 13, Iss. 4, pp. 217-231
Open Access | Times Cited: 847
Mechanisms of α-Synuclein Induced Synaptopathy in Parkinson's Disease
Jéssika Cristina Bridi, Frank Hirth
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 300
The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease
Martí Colom‐Cadena, Tara L. Spires‐Jones, Henrik Zetterberg, et al.
Alzheimer s Research & Therapy (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 247
The landscape of aging
Yusheng Cai, Wei Song, Jiaming Li, et al.
Science China Life Sciences (2022) Vol. 65, Iss. 12, pp. 2354-2454
Open Access | Times Cited: 239
Dementia with Lewy bodies and Parkinson’s disease-dementia: current concepts and controversies
K. A. Jellinger
Journal of Neural Transmission (2017) Vol. 125, Iss. 4, pp. 615-650
Closed Access | Times Cited: 231
Molecular biomarkers of Alzheimer's disease: progress and prospects
Tammaryn Lashley, Jonathan M. Schott, Philip S.J. Weston, et al.
Disease Models & Mechanisms (2018) Vol. 11, Iss. 5
Open Access | Times Cited: 206
Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approach
Erika Bereczki, Rui M. Branca, Paul T. Francis, et al.
Brain (2017) Vol. 141, Iss. 2, pp. 582-595
Open Access | Times Cited: 201
Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications
Zhen Yan, Benjamin Rein
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 445-465
Open Access | Times Cited: 192
Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age
Aliza P. Wingo, Eric B. Dammer, Michael S. Breen, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 185
Blood neuro‐exosomal synaptic proteins predict Alzheimer's disease at the asymptomatic stage
Longfei Jia, Min Zhu, Chaojun Kong, et al.
Alzheimer s & Dementia (2020) Vol. 17, Iss. 1, pp. 49-60
Open Access | Times Cited: 182
Tau accumulation in astrocytes of the dentate gyrus induces neuronal dysfunction and memory deficits in Alzheimer’s disease
Kevin Richetin, Pascal Steullet, Mathieu Pachoud, et al.
Nature Neuroscience (2020) Vol. 23, Iss. 12, pp. 1567-1579
Closed Access | Times Cited: 174
Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Current Evidence and Future Perspectives
Donovan McGrowder, Fabian Miller, Kurt Vaz, et al.
Brain Sciences (2021) Vol. 11, Iss. 2, pp. 215-215
Open Access | Times Cited: 108
Stem cell-derived neurons reflect features of protein networks, neuropathology, and cognitive outcome of their aged human donors
Valentina N. Lagomarsino, Richard V. Pearse, Lei Liu, et al.
Neuron (2021) Vol. 109, Iss. 21, pp. 3402-3420.e9
Open Access | Times Cited: 104
Synaptic phosphorylated α-synuclein in dementia with Lewy bodies
Martí Colom‐Cadena, Jordi Pegueroles, Abigail G. Herrmann, et al.
Brain (2017) Vol. 140, Iss. 12, pp. 3204-3214
Open Access | Times Cited: 110
Fluid biomarkers in frontotemporal dementia: past, present and future
Imogen J. Swift, Aitana Sogorb‐Esteve, Carolin Heller, et al.
Journal of Neurology Neurosurgery & Psychiatry (2020) Vol. 92, Iss. 2, pp. 204-215
Open Access | Times Cited: 102
Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer’s disease pathogenesis
Kunal Dhiman, Kaj Blennow, Henrik Zetterberg, et al.
Cellular and Molecular Life Sciences (2019) Vol. 76, Iss. 10, pp. 1833-1863
Open Access | Times Cited: 90
Integrating Gene and Protein Expression Reveals Perturbed Functional Networks in Alzheimer’s Disease
Saranya Canchi, Balaji Raao, Deborah Masliah, et al.
Cell Reports (2019) Vol. 28, Iss. 4, pp. 1103-1116.e4
Open Access | Times Cited: 79
Reduced Synaptic Density in Patients with Lewy Body Dementia: An [11C]UCB‐J PET Imaging Study
Katrine B. Andersen, Allan K. Hansen, Malene Flensborg Damholdt, et al.
Movement Disorders (2021) Vol. 36, Iss. 9, pp. 2057-2065
Open Access | Times Cited: 58
Recent Development in the Understanding of Molecular and Cellular Mechanisms Underlying the Etiopathogenesis of Alzheimer’s Disease
Atefeh Afsar, Maria del Carmen Chacon Castro, Adedamola Saidi Soladogun, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7258-7258
Open Access | Times Cited: 23
Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers
Lucy L. Gibson, Carla Abdelnour, Joyce R. Chong, et al.
Current Opinion in Neurology (2023)
Open Access | Times Cited: 23
Regional differences in synaptic degeneration are linked to alpha-synuclein burden and axonal damage in Parkinson’s disease and dementia with Lewy bodies
Irene Frigerio, Maud M.A. Bouwman, Ruby T G M M Noordermeer, et al.
Acta Neuropathologica Communications (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 13
Delivering synaptic protein mRNAs via extracellular vesicles ameliorates cognitive impairment in a mouse model of Alzheimer’s disease
Huimin Cai, Yana Pang, Ziye Ren, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Alzheimer's disease neuropathology and its estimation with fluid and imaging biomarkers
Dietmar Rudolf Thal, Koen Poesen, Rik Vandenberghe, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Mild Cognitive Impairment in Parkinson’s Disease—What Is It?
Rimona S. Weil, Alyssa Costantini, Anette Schrag
Current Neurology and Neuroscience Reports (2018) Vol. 18, Iss. 4
Open Access | Times Cited: 74
Living in Promiscuity: The Multiple Partners of Alpha-Synuclein at the Synapse in Physiology and Pathology
Francesca Longhena, Gaia Faustini, Maria Grazia Spillantini, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 1, pp. 141-141
Open Access | Times Cited: 70
Page 1 - Next Page

Scroll to top